Portnoy Mark L. 4
4 · CRYO CELL INTERNATIONAL INC · Filed May 26, 2021
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Exercise/Conversion
Stock Option
2021-05-24$1.72/sh−200,000$344,000→ 0 totalExercise: $1.72From: 2011-12-01Exp: 2021-12-01→ Common Stock (200,000 underlying) - Exercise/Conversion
Common Stock
2021-05-24$2.90/sh+32,184$93,334→ 719,698 total - Exercise/Conversion
Stock Option
2021-05-24$2.90/sh−32,184$93,334→ 67,816 totalExercise: $2.90From: 2011-08-31Exp: 2021-08-31→ Common Stock (100,000 underlying) - Exercise/Conversion
Common Stock
2021-05-24$1.72/sh+200,000$344,000→ 687,514 total
Holdings
- 59,459
Stock Option
Exercise: $3.14From: 2016-04-15Exp: 2026-04-15→ Common Stock (59,459 underlying) - 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying) - 42,266(indirect: By 401(k))
Common Stock
- 71,529(indirect: By Partnership)
Common Stock
- 20,000
Stock Option
Exercise: $7.92From: 2018-03-08Exp: 2028-03-08→ Common Stock (20,000 underlying) - 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying)
Footnotes (2)
- [F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
- [F2]Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.